Edition:
United Kingdom

Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

8.59USD
16 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.59
Open
$8.74
Day's High
$8.87
Day's Low
$8.55
Volume
106,002
Avg. Vol
203,896
52-wk High
$43.98
52-wk Low
$7.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.21 December 17 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 7 7 7 8
(3) HOLD 2 2 2 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.92 1.92 1.92 1.83

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 6 14.23 15.00 12.89 --
Quarter Ending Jun-19 6 16.96 19.00 14.68 --
Year Ending Dec-19 10 69.55 83.80 60.00 92.09
Earnings (per share)
Quarter Ending Mar-19 5 -1.21 -1.18 -1.25 --
Quarter Ending Jun-19 5 -1.13 -1.07 -1.21 --
Year Ending Dec-19 11 -4.33 -3.35 -5.89 -2.43
LT Growth Rate (%) 1 17.90 17.90 17.90 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 10.17 10.61 0.45 4.38
Quarter Ending Jun-18 4.86 7.57 2.71 55.71
Quarter Ending Mar-18 1.60 2.55 0.95 59.48
Quarter Ending Dec-17 0.84 0.57 0.27 32.24
Quarter Ending Sep-17 0.03 0.00 0.03 97.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-19 14.23 14.23 13.10 13.10 --
Quarter Ending Jun-19 16.96 16.96 16.20 16.20 --
Year Ending Dec-19 69.55 69.55 73.99 77.81 92.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-19 0 0 1 0
Quarter Ending Jun-19 0 0 1 0
Year Ending Dec-19 0 0 0 4
Earnings